The tight skin mouse: An animal model of systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 22, Issue 3 SUPPL. 33, 2004, Pages

  Pablos, José L ^a   Everett, Eric T ^b   Norris, James S ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Animal model; Autoantibodies; Collagen; Fibroblasts; Mast cells; Systemic sclerosis

Indexed keywords

FIBRILLIN 1; MESSENGER RNA; SCLEROPROTEIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; AUTOANTIBODY;

ALLELE; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL INFILTRATION; CELL TYPE; EXTRACELLULAR MATRIX; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HOMEOSTASIS; IMMUNOPATHOLOGY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; DELAYED HYPERSENSITIVITY; FIBROBLAST; FIBROSIS; GENETICS; MAST CELL; MOUSE MODEL; MOUSE STRAIN; TSK1 MOUSE;

ANIMALS; CHICKENS; COLLAGEN; FIBROBLASTS; MICE; MICE, INBRED STRAINS; MICROFILAMENT PROTEINS; MODELS, ANIMAL; SCLERODERMA, SYSTEMIC; SKIN;

EID: 4444309488     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. JIMENEZ SA, CHRISTNER PJ: Murine animal models of systemic sclerosis. Curr Opin Rheumatol 2002; 14: 671-80.
2. DeLUSTRO FA, MACKEL AM, LeROY EC: Delayed-type hypersensitivity to elastase-soluble lung peptides in the tight-skin (Tsk) mouse. Cell Immunol 1983; 81: 175-9.
3. MURAI C, SAITO S, KATURI KN, BONA CA: Spontaneous occurence of anti-fibrillin-1 autoantibodies in tight-skin mice. Autoimmunity 1998; 28: 151-5:
4. TAN FK, ARNETT FC, ANTOHI S et al.: Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol 1999; 163: 1066-72.
5. LeROY EC: Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med 1972; 135: 1351-62.
6. SCHARFFETTER K, LANKAT-BUTTGEREIT B, KRIEG T: Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 1988; 18: 9-17.
7. ZHANG Y, GILLIAM AC: Animal models for scleroderma: an update. Curr Rheumatol Rep 2002; 4: 150-62.
8. ROSE NR: Avian models of autoimmune disease: lessons from the birds. Poult Sci 1994; 73: 984-90.
9. PANDEY JP, LeROY EC: Human cytomegaloviros and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary retenosis. Arthritis Rheum 1998; 41: 10-51.
10. HAMAMDZIC D, HARLEY RA, HAZEN-MARTIN D, LeROY EC: MCMV induces neointima in IFN-gammaR-/- mice: Intimal cell apoptosis and persistent proliferation of myofibroblasts. BMC Musculoskelet Disord 2001; 2: 3.
11. GREEN MC, SWEET HO, BUNKER LE: Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 1976; 82: 493-512.
12. EVERETT ET, PABLOS JL, HARRIS SE, LeROY EC, NORRIS JS: The tight-skin (Tsk) mutation is closely linked to B2m on mouse chromosome 2. Mamm Genome 1994; 5: 55-7.
13. SIRACUSA LD, CHRISTNER P, McGRATH R, MOWERS SD, NELSON KK, JIMENEZ SA: The tight skin (Tsk) mutation in the mouse, a model for human fibrotic diseases, is tightly linked to the beta 2-microglobulin (B2m) gene on chromosome 2. Genomics 1993; 17: 748-51.
14. SIRACUSA LD, McGRATH R, MA Q et al.: A tandem duplication within the fibrillin 1 gene is associated with to mouse tight skin mutation. Genome Res 1996;6:300-13.
15. KIELTY CM, RAGHUNATH M, SIRACUSA LD et al.: The tight skin mouse: demonstration of mutant fibrillin-1 production and assemby into abnormal microfibrils. J Cell Biol 1998; 140: 1159-66.
16. GAYRAUD B, KEENE DR, SAKAI LY, RAMIREZ F: New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin 1 mutation in the tight skin mouse. J Cell Biol 2000; 150: 667-80.
17. SAITO S, NISHIMURA H, PHELPS RG et al.: Induction of skin fibrosis in mice expressing a mutated fibrillin-1 gene. Mol Med 2000; 6: 825-36.
18. ONG CJ, IP S, TEH SJ et al.: A role for T helper 2 cells in mediating skin fibrosis in tight-skin mice. Cell Immunol 1999; 196: 60-8.
19. McGAHA T, SAITO S, PHELPS RG et al.: Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J Invest Dermatol 2001; 116: 136-43.
20. ISOGAI Z, ONO RN, USHIRO S et al.: Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003; 278: 2750-7.
21. NEPTUNE ER, FRISCHMEYER PA, ARKING DE et al.: Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407-11.
22. PHELPS RG, MURAI C, SAITO S et al.: Effect of targeted mutation in collagen V alpha 2 gene on development of cutaneous hyperplasia in tight skin mice. Mol Med 1998; 4: 356-60.
23. DENTON CP, ZHENG B, SHIWEN X et al.: Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice. Arthritis Rheum 2001; 44: 712-22.
24. WALKER MA, HARLEY RA, DeLUSTRO FA, LeROY EC: Adoptive transfer of tsk skin fibrosis to +/+ recipients by tsk bone marrow and spleen cells. Proc Soc Exp Biol Med 1989; 192: 196-200.
25. SIRACUSA LD, McGRATH R, FISHER JK, JIMENEZ SA: The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes. Mamm Genome 1998; 9: 907-9.
26. DODIG TD, MACK KT, CASSARINO DF, CLARK SH. Development of the tight-skin phenotype in immune-deficient mice. Arthritis Rheum 2001; 44: 723-7.
27. BOCCHIERI MH, HENRIKSEN PD, KASTURI KN, MURYOI T, BONA CA, JIMENEZ SA: Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis Rheum 1991; 34: 599-605.
28. MURYOI T, ANDRE-SCHWARTZ J, SAITOH Y et al.: Self-reactive repertoire of tight skin (TSK/+) mouse: immunochemical and molecular characterization of anti-cellular autoantibodies. Cell Immunol 1992; 144: 43-54.
29. SHIBATA S, MURY0I T, SAITOH Y, BRUMEANU TD, BONA CA, KASTURI KN: Immunochemical and molecular characterization of anti-RNA polymerase 1 autoantibodies produced by tight skin mouse. J Clin Invest 1993; 92: 984-92.
30. MARIE I, BENY JL: Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1. J Invest Dermatol 2002; 119: 1379-87.
31. CASCIOLA-ROSEN L, WIGLEY F, ROSEN A: Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997; 185: 17-9.
32. JIMENEZ SA, WILLIAMS CJ, MYERS JC, BASHEY RI: Increased collagen biosynthesis and increased expression of type I and type III procollagen genes in tight skin (TSK) mouse fibroblasts. J Biol Chem 1986; 261: 657-62.
33. WALKER M, HARLEY R, MAIZE J, DeLUSTRO F, LeROY EC: Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med 1985; 180: 323-8.
34. PABLOS JL, EVERETT ET, BARLEY R, LeROY EC, NORRIS JS: Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Lab Invest 1995; 72: 670-8
35. McGAHA T, KODERA T, PHELPS R et al.: Effect of halofuginone on the development of light skin (TSK) syndrome. Autoimmunity 2002; 35: 277-82.
36. ONG C, WONG C, ROBERTS CR, TEH HS, JIRIK FR: Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma. Eur J Immunol 1998; 28: 2619-29.
37. DELANY AM, BRINCKERHOFF CE: The synthetic retinoid (4-hydroxyphenyl)retinamide decreases collagen expression in vitro and in the tight-skin mouse. Anthritis Rheum 1993; 36: 983-93.
38. WALKER MA, HARLEY RA, LeROY EC: Inhibition of fibrosis in TSK mice by blocking mast cell degranulation. J Rheumatol 1987; 14: 299-301.
39. WALKER M, HARLEY R, LeROY EC: Ketotifen prevents skin fibrosis in the tight skin mouse J Rheumatol 1990; 17: 57-9.
40. EVERETT ET, PABLOS JL, HARLEY RA, LeROY EC, NORRIS JS: The role of mast cells in the developmental of skin fibrosis in tight-skin mutant mice. Comp Biochem Physiol 1995; 110A: 159-65.
41. SEIBOLD JR, GIORNO RC, CLAMAN HN: Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990; 33: 1702-9.